neoplasm

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

Completed
  • Melanoma
  • +3 more
  • San Francisco, California
  • +15 more
Jul 28, 2020

Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

Completed
  • Cancer
  • +18 more
  • ASN007: ascending doses
  • ASN007 RD
  • Tampa, Florida
  • +4 more
Jul 7, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Tumor Trial in United States (Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg, Escalation cohort: Regorafenib

Completed
  • Neoplasm
  • Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg
  • +7 more
  • Los Angeles, California
  • +4 more
Nov 16, 2015

Carcinoma, Non-small-cell Lung, Metastases Trial in United States (ZD1839 (Gefitinib))

Completed
  • Carcinoma
  • +3 more
  • ZD1839 (Gefitinib)
  • Alabaster, Alabama
  • +626 more
Jan 3, 2013

Tumor Trial in United States (PTK787/ZK222584)

Completed
  • Neoplasm
  • Scottsdale, Arizona
  • +6 more
May 8, 2012